Philippe Beuzeboc Selected Research

Therapeutics

11/2023	Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma.
10/2023	Very Long-Term Complete Remission Can Be Achieved in Men With High-Risk Localized Prostate Cancer and a Very High PSA Value: An Analysis of the GETUG 12 Phase 3 Trial.
10/2022	Clinical Benefit of Pembrolizumab in Advanced Urothelial Cancer Patients in Real-Life Setting: An Efficacy and Safety Monocentric Study.
1/2022	Letter comments on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single-centre prospective study: Interaction between lymphopenia and anti-SARS-CoV-2 antibodies after two injections of the Pfizer-BioNTech vaccine in patients with cancers treated by chemotherapy or immunotherapy.
1/2021	TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors.
1/2020	Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database.
5/2019	Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial.
1/2019	French recommendations for osteoporosis prevention and treatment in patients with prostate cancer treated by androgen deprivation.
12/2018	Sequencing of Taxanes and New Androgen-targeted Therapies in Metastatic Castration-resistant Prostate Cancer: Results of the International Multicentre Retrospective CATS Database.
1/2018	Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philippe Beuzeboc Research Topics

Disease

45	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 01/2002
32	Neoplasms (Cancer) 04/2024 - 04/2002
14	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2002
13	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2002
9	Carcinoma (Carcinomatosis) 11/2023 - 11/2003
6	Disease Progression 09/2020 - 05/2009
5	Pain (Aches) 03/2022 - 05/2009
4	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024 - 01/2004
4	Neutropenia 01/2020 - 02/2013
3	Lung Neoplasms (Lung Cancer) 07/2015 - 01/2009
2	Fatigue 03/2022 - 01/2012
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 09/2009
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 06/2012
2	Hypertension (High Blood Pressure) 01/2022 - 11/2015
2	Febrile Neutropenia 05/2019 - 02/2013
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2015 - 01/2011
2	Head and Neck Neoplasms (Head and Neck Cancer) 06/2015 - 01/2002
2	Seminoma 02/2014 - 02/2003
2	Cardiotoxicity 06/2011 - 03/2007
2	Transitional Cell Carcinoma 07/2009 - 11/2005
1	COVID-19 01/2023
1	Alopecia (Baldness) 03/2022
1	Edema (Dropsy) 03/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Liver Failure 01/2022
1	Digestive System Diseases 01/2022
1	Thrombotic Microangiopathies 01/2022
1	Heart Failure 01/2022
1	Massive Hepatic Necrosis 01/2022

Drug/Important Bio-Agent (IBA)

22	Docetaxel (Taxotere)FDA Link 10/2023 - 05/2005
19	AndrogensIBA 10/2023 - 11/2003
12	Hormones (Hormone)IBA 05/2019 - 11/2003
7	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 10/2005
7	Prostate-Specific Antigen (Semenogelase)IBA 10/2023 - 05/2009
6	PlatinumIBA 04/2024 - 07/2009
6	Estramustine FDA Link 10/2023 - 05/2005
6	cabazitaxel FDA Link 03/2022 - 04/2011
6	Trastuzumab (Herceptin)FDA Link 01/2017 - 05/2004
5	Gemcitabine FDA Link 11/2023 - 10/2005
5	AnthracyclinesIBA 01/2017 - 04/2002
5	CreatinineIBA 12/2010 - 10/2005
4	Abiraterone AcetateIBA 02/2023 - 07/2012
4	Taxoids (Taxanes)IBA 03/2022 - 12/2010
4	Monoclonal AntibodiesIBA 01/2021 - 05/2004
3	abirateroneIBA 01/2023 - 08/2015
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2012
3	ErbB Receptors (EGF Receptor)IBA 01/2021 - 11/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 07/2004
3	Prednisone (Sone)FDA LinkGeneric 12/2020 - 05/2005
3	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 12/2014
3	SaltsIBA 01/2015 - 03/2012
3	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2011 - 05/2005
2	sacituzumab govitecanIBA 04/2024 - 01/2021
2	NivolumabIBA 11/2023 - 01/2022
2	VaccinesIBA 01/2023 - 01/2022
2	olaparibIBA 01/2023 - 12/2020
2	pembrolizumabIBA 10/2022 - 01/2020
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 12/2020
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 11/2003
2	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 01/2017
2	Denosumab FDA Link 01/2019 - 11/2012
2	Diphosphonates (Bisphosphonates)IBA 01/2019 - 05/2014
2	Bevacizumab (Avastin)FDA Link 01/2017 - 11/2015
2	enzalutamideIBA 08/2015 - 01/2014
2	Alkaline PhosphataseIBA 08/2015 - 02/2012
2	Zoledronic Acid (Zometa)FDA Link 05/2014 - 11/2012
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2014 - 02/2013
2	Etoposide (VP 16)FDA LinkGeneric 02/2014 - 07/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2012 - 07/2004
2	ZD4054IBA 10/2010 - 05/2009
2	Pain-FreeIBA 10/2010 - 05/2009
2	Endothelin A ReceptorIBA 10/2010 - 05/2009
2	human ERBB2 proteinIBA 03/2007 - 05/2004
1	Immune Checkpoint InhibitorsIBA 04/2024
1	darolutamideIBA 10/2023
1	Lipase (Acid Lipase)FDA Link 01/2022
1	BNT162 VaccineIBA 01/2022
1	IpilimumabIBA 01/2022
1	Sunitinib (Sutent)FDA Link 01/2022
1	AntibodiesIBA 01/2022
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2021
1	Panitumumab (Vectibix)FDA Link 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	EnzymesIBA 12/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2020

Therapy/Procedure

33	Drug Therapy (Chemotherapy) 04/2024 - 01/2002
30	Therapeutics 11/2023 - 01/2003
24	Castration 10/2023 - 05/2009
7	Radiotherapy 10/2021 - 01/2004
3	Adjuvant Chemotherapy 01/2017 - 07/2006
3	Cystectomy 01/2017 - 01/2004
2	Duration of Therapy 01/2020 - 04/2015
2	Chemoradiotherapy 06/2015 - 01/2004
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 06/2012 - 09/2009
2	Lymph Node Excision (Lymph Node Dissection) 01/2012 - 02/2003
2	Drug Tapering 12/2010 - 10/2009
2	Aftercare (After-Treatment) 05/2009 - 04/2002
1	Immunotherapy 01/2022
1	Injections 01/2022
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021